Kalpana Kalpana (Editor)

Sphingolipidoses

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Specialty
  
endocrinology

ICD-9-CM
  
272.7

MeSH
  
D013106

ICD-10
  
E75.3

DiseasesDB
  
33438

Sphingolipidoses

Sphingolipidoses (singular "sphingolipidosis") are a class of lipid storage disorders relating to sphingolipid metabolism. The main members of this group are Niemann–Pick disease, Fabry disease, Krabbe disease, Gaucher disease, Tay–Sachs disease and metachromatic leukodystrophy. They are generally inherited in an autosomal recessive fashion, but notably Fabry disease is X-linked recessive. Taken together, sphingolipidoses have an incidence of approximately 1 in 10,000, but substantially more in certain populations such as Ashkenazi Jews. Enzyme replacement therapy is available to treat mainly Fabry disease and Gaucher disease, and people with these types of sphingolipidoses may live well into adulthood. The other types are generally fatal by age 1 to 5 years for infantile forms, but progression may be mild for juvenile- or adult-onset forms.

Accumulated products

  • Gangliosides: Gangliosidosis
  • GM1 gangliosidoses
  • GM2 gangliosidoses
  • Tay-Sachs disease
  • Sandhoff disease
  • Glycolipids
  • Fabry's disease
  • Krabbe disease
  • Metachromatic leukodystrophy
  • Glucocerebrosides
  • Gaucher's disease
  • References

    Sphingolipidoses Wikipedia